v3.25.2
Condensed Consolidated Statements of Loss and Comprehensive Loss - USD ($)
3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]            
Net Sales $ 2,556,223 $ 2,688,533 $ 5,191,941 $ 5,064,926 $ 9,686,975 $ 11,087,459
Cost of Sales 1,272,176 1,493,566 2,703,660 2,853,799 5,437,484 6,913,902
Gross Profit 1,284,047 1,194,967 2,488,281 2,211,127 4,249,491 4,173,557
Operating Expenses            
Selling expenses 309,179 405,212 636,775 964,682 1,557,508 2,417,479
General and administrative expenses 1,170,842 1,287,937 2,240,450 2,481,802 6,057,477 5,056,500
Research and development 520 (518) 910 750,698 1,997,861 3,118,126
Total Operating Expenses 1,480,541 1,692,631 2,878,135 4,197,182 9,612,846 10,592,105
Loss From Operations (196,494) (497,664) (389,854) (1,986,055) (5,363,355) (6,418,548)
Other Income (Expenses)            
Non-operating income 376 1,162 77,269 2,743 4,496 19,979
Loss on impairment of goodwill (218,606)    
Foreign exchange transaction income (loss) (28,063) (2,383) (32,050) 70,649 13,281 (417,690)
Interest expense, net (10,927) (8,626) (18,689) (12,568) (31,244) (9,495)
Financial expense (55,796) (51,102) (110,105) (96,138) (182,269) (166,411)
Total Other Expenses, Net (94,410) (60,949) (302,181) (35,314) (195,736) (573,617)
Loss Before Income Taxes (290,904) (558,613) (692,035) (2,021,369) (5,559,091) (6,992,165)
Income Tax Benefit (Expense) 997 (4,876) 63,257 (4,876) (2,614) (731,092)
Net Loss (289,907) (563,489) (628,778) (2,026,245) (5,561,705) (7,723,257)
Other Comprehensive Loss            
Foreign currency translation (23,731) (909) (26,706) (82,600) 721 444,183
Net Loss and Comprehensive Loss $ (313,638) $ (564,398) $ (655,484) $ (2,108,845) $ (5,560,984) $ (7,279,074)
Weighted average shares outstanding - Basic 13,729,976 [1] 2,538,792 [1] 11,766,186 [1] 2,387,653 [1] 3,765,727 [2] 1,556,555 [2]
Weighted average shares outstanding - Diluted 13,729,976 [1] 2,538,792 [1] 11,766,186 [1] 2,387,653 [1] 3,765,727 [2] 1,556,555 [2]
Net loss per share of common stock            
Basic $ (0.02) $ (0.22) $ (0.05) $ (0.85) $ (1.48) $ (4.96)
Diluted $ (0.02) $ (0.22) $ (0.05) $ (0.85) $ (1.48) $ (4.96)
[1] Including 1,500 and 0 shares that were granted and vested but not yet issued for the six and three months ended June 30, 2025 and 2024, respectively.
[2] Including 1,500 and 0 shares that were granted and vested but not yet issued for the years ended December 31, 2024 and 2023, respectively.